373 results on '"Barrera, Giuseppina"'
Search Results
2. MYC and MET cooperatively drive hepatocellular carcinoma with distinct molecular traits and vulnerabilities
3. Glutathione-responsive cyclodextrin-nanosponges as drug delivery systems for doxorubicin: Evaluation of toxicity and transport mechanisms in the liver
4. Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism
5. Post-translational inhibition of YAP oncogene expression by 4-hydroxynonenal in bladder cancer cells
6. Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression.
7. Contributors
8. Nrf2, YAP, antioxidant potential, and cancer
9. Novel tetrahydroacridine derivatives with iodobenzoic moieties induce G0/G1 cell cycle arrest and apoptosis in A549 non-small lung cancer and HT-29 colorectal cancer cells
10. Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer
11. KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: Implication for Cerebral Cavernous Malformation disease
12. Nrf2 as a Therapeutic Target in the Resistance to Targeted Therapies in Melanoma
13. GSH-targeted nanosponges increase doxorubicin-induced toxicity “in vitro” and “in vivo” in cancer cells with high antioxidant defenses
14. Supplementary Figure 7 from Immunotargeting of Antigen xCT Attenuates Stem-like Cell Behavior and Metastatic Progression in Breast Cancer
15. Supplementary Figure 5 from Immunotargeting of Antigen xCT Attenuates Stem-like Cell Behavior and Metastatic Progression in Breast Cancer
16. Supplememtary methods from Immunotargeting of Antigen xCT Attenuates Stem-like Cell Behavior and Metastatic Progression in Breast Cancer
17. Supplementary Figure 1 from Immunotargeting of Antigen xCT Attenuates Stem-like Cell Behavior and Metastatic Progression in Breast Cancer
18. Supplementary Figure 4 from Immunotargeting of Antigen xCT Attenuates Stem-like Cell Behavior and Metastatic Progression in Breast Cancer
19. Supplementary Figure 2 from Immunotargeting of Antigen xCT Attenuates Stem-like Cell Behavior and Metastatic Progression in Breast Cancer
20. Data from Immunotargeting of Antigen xCT Attenuates Stem-like Cell Behavior and Metastatic Progression in Breast Cancer
21. Supplementary Figure 6 from Immunotargeting of Antigen xCT Attenuates Stem-like Cell Behavior and Metastatic Progression in Breast Cancer
22. Supplementary Figure 3 from Immunotargeting of Antigen xCT Attenuates Stem-like Cell Behavior and Metastatic Progression in Breast Cancer
23. Microbiota, Oxidative Stress, and Skin Cancer: An Unexpected Triangle
24. The inclusion complex of 4-hydroxynonenal with a polymeric derivative of β-cyclodextrin enhances the antitumoral efficacy of the aldehyde in several tumor cell lines and in a three-dimensional human melanoma model
25. Nanosponge-encapsulated camptothecin exerts anti-tumor activity in human prostate cancer cells
26. MYC and MET cooperatively drive hepatocellular carcinoma with distinct molecular traits and vulnerabilities
27. Enzymes Metabolizing Aldehydes in HL-60 Human Leukemic Cells
28. Nuclear factor erythroid 2-related factor-2 activity controls 4-hydroxynonenal metabolism and activity in prostate cancer cells
29. PPARγ in coronary atherosclerosis: In vivo expression pattern and correlations with hyperlipidemic status and statin treatment
30. Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cells
31. Contributors
32. Differentiating Agents and Cancer Therapy. Role of Cellular Lipid Peroxidation and its Product 4-Hydroxynonenal in the Control of Cell Proliferation and Differentiation
33. 4-Hydroxynonenal, a lipid peroxidation product of dietary polyunsaturated fatty acids, has anticarcinogenic properties in colon carcinoma cell lines through the inhibition of telomerase activity
34. Action of the Aldehydes Derived from Lipid Peroxidation on Isolated Liver Plasmamembranes
35. Oxidative Stress-Related Mechanisms in Melanoma and in the Acquired Resistance to Targeted Therapies
36. MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation
37. Chapter 15 - Nrf2, YAP, antioxidant potential, and cancer
38. Peroxisome Proliferator-Activated Receptors (PPARs) and Oxidative Stress in Physiological Conditions and in Cancer
39. Lipid peroxidation: control of cell proliferation, cell differentiation and cell death
40. 4-Hydroxynonenal and PPARγ ligands affect proliferation, differentiation, and apoptosis in colon cancer cells
41. Control of Oxidative Stress in Cancer Chemoresistance: Spotlight on Nrf2 Role
42. 4-Hydroxynonenal inhibits telomerase activity and hTERT expression in human leukemic cell lines
43. Corrigendum to “Drug Delivery Nanoparticles in Skin Cancers”
44. Carbosilane Dendrimers Loaded with siRNA Targeting Nrf2 as a Tool to Overcome Cisplatin Chemoresistance in Bladder Cancer Cells
45. PPARγ ligands inhibit telomerase activity and hTERT expression through modulation of the Myc/Mad/Max network in colon cancer cells
46. 4-Hydroxynonenal modulation of p53 family gene expression in the SK-N-BE neuroblastoma cell line
47. 4-Hydroxynonenal and cell cycle
48. 4-hydroxynonenal and regulation of cell cycle: effects on the pRb/E2F pathway
49. Effect of Bioactive Aldehydes on Cell Proliferation and c-Myc Expression in HL-60 Human Leukemic Cells
50. Improvement in the Anti-Tumor Efficacy of Doxorubicin Nanosponges in In Vitro and in Mice Bearing Breast Tumor Models
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.